This is the status of American healthcare companies in Russia following the February invasion of Ukraine:
Still operating:
Align Technology: Phoenix-based manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics
Amgen: biopharmaceutical company headquartered in Thousand Oaks, Calif.
Suspended some operations:
AmerisourceBergen: The Conshohocken, Pa.-based drug distribution and consulting company has ended all new business initiatives in Russia but will continue ongoing clinical trials and distribution of its health products.
Abbott Laboratories: The Abbott Park, Ill.-based medical manufacturer has suspended all nonessential business.
Eli Lilly: The Indianapolis-based pharmaceutical company has suspended all new investments and clinical trials.
Johnson & Johnson: The multinational pharmaceutical corporation headquartered in New Brunswick, N.J., has paused patient enrollment in ongoing trials.
AbbVie: The biopharmaceutical firm headquartered in North Chicago, Ill., has suspended aesthetics operations and paused all clinical trials.
Merck: The Kenilworth, N.J.-based pharmaceutical company will not make new investments or conduct clinical trial enrollments going forward.
Pfizer: The New York City-based pharmaceutical and biotechnology corporation will not make new investments or conduct new clinical trials going forward.
Suspended operations:
Conformis: The medical device manufacturer headquartered in Billerica, Mass., has suspended all distribution operations.
Mettler Toledo: The Columbus, Ohio-based medical laboratory device manufacturer has suspended all shipments.
SonoSim: The medical software developer headquartered in Santa Monica, Calif., has suspended its distributor relationships in Russia.
Thermo Fisher Scientific: The Waltham, Mass.-based medical equipment supplier has suspended all sales and manufacturing.
Waters Corp: The medical equipment manufacturer and software developer headquartered in Milford, Mass., has suspended all sales and services.
